1. Home
  2. MEI vs CRDF Comparison

MEI vs CRDF Comparison

Compare MEI & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEI
  • CRDF
  • Stock Information
  • Founded
  • MEI 1946
  • CRDF 1999
  • Country
  • MEI United States
  • CRDF United States
  • Employees
  • MEI N/A
  • CRDF N/A
  • Industry
  • MEI Electrical Products
  • CRDF Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MEI Technology
  • CRDF Health Care
  • Exchange
  • MEI Nasdaq
  • CRDF Nasdaq
  • Market Cap
  • MEI 231.0M
  • CRDF 233.5M
  • IPO Year
  • MEI N/A
  • CRDF N/A
  • Fundamental
  • Price
  • MEI $6.87
  • CRDF $2.44
  • Analyst Decision
  • MEI Buy
  • CRDF Strong Buy
  • Analyst Count
  • MEI 2
  • CRDF 6
  • Target Price
  • MEI $10.50
  • CRDF $10.58
  • AVG Volume (30 Days)
  • MEI 433.4K
  • CRDF 3.2M
  • Earning Date
  • MEI 09-04-2025
  • CRDF 07-29-2025
  • Dividend Yield
  • MEI 4.14%
  • CRDF N/A
  • EPS Growth
  • MEI N/A
  • CRDF N/A
  • EPS
  • MEI N/A
  • CRDF N/A
  • Revenue
  • MEI $1,048,100,000.00
  • CRDF $545,000.00
  • Revenue This Year
  • MEI N/A
  • CRDF N/A
  • Revenue Next Year
  • MEI $2.28
  • CRDF N/A
  • P/E Ratio
  • MEI N/A
  • CRDF N/A
  • Revenue Growth
  • MEI N/A
  • CRDF N/A
  • 52 Week Low
  • MEI $5.08
  • CRDF $2.09
  • 52 Week High
  • MEI $17.45
  • CRDF $5.64
  • Technical
  • Relative Strength Index (RSI)
  • MEI 47.90
  • CRDF 34.61
  • Support Level
  • MEI $6.21
  • CRDF $2.30
  • Resistance Level
  • MEI $7.17
  • CRDF $2.50
  • Average True Range (ATR)
  • MEI 0.23
  • CRDF 0.23
  • MACD
  • MEI 0.14
  • CRDF -0.05
  • Stochastic Oscillator
  • MEI 74.77
  • CRDF 7.18

About MEI Methode Electronics Inc.

Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles, including overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors.

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.

Share on Social Networks: